Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou don't need to exercise on Wegovy for the medicine to work. Clinical trials of semaglutide 2.4mg achieved substantial average weight reductions even when structured exercise wasn't the primary variable. That said, physical activity changes what kind of weight you lose, how you feel week to week, and what happens to your body composition over time — and those differences matter more than most people expect. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses whether it's clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy suppresses hunger through the GLP-1 pathway, slowing gastric emptying and signalling fullness more persistently. The STEP 1 trial (68 weeks, over 1,900 adults) reported an average body-weight reduction of around 15% at the 2.4mg maintenance dose, and participants weren't enrolled in a specific structured exercise programme. So if you're asking whether you have to exercise on Wegovy to see results, the honest answer is: probably not, if you're clinically suitable and the medicine is working as it should.
But weight loss and fat loss aren't identical. When your calorie intake drops sharply, as it tends to on semaglutide, your body draws on both fat stores and lean tissue. Studies on GLP-1 medicines have shown that a meaningful proportion of total weight lost can be muscle, particularly without any resistance or load-bearing activity. Muscle loss matters because it affects your metabolism, your strength, and how sustainable your results are long-term. This is the part that gets glossed over in most popular coverage of the medicine.
You can explore how the two interact in more detail on our Wegovy and exercise guide, which covers specific activity types and the evidence behind them.
The UK licence for Wegovy explicitly positions it as an adjunct to a reduced-calorie diet and increased physical activity. That wording sometimes makes people assume exercise is compulsory or that missing a gym session will undermine the treatment. It won't. "Increased physical activity" is a clinical term describing the direction of travel, not a minimum step count.
For someone who currently walks very little, adding a 20-minute walk most days meets the spirit of the guidance. NHS Better Health activity recommendations set a target of 150 minutes of moderate activity weekly for adults (brisk walking, cycling, swimming, gardening) none of which requires a gym membership or a formal exercise plan.
That said, if you want to make the most of the muscle-preservation question, some load-bearing activity (bodyweight exercises, resistance bands, or weights) does appear to help in the evidence. Our guide to exercise types on Wegovy breaks this down without the jargon. The prescriber reviewing your consultation can also advise based on your specific health picture; treatment cost includes that ongoing clinical support at no extra charge.
There's a version of this question that really means: "If I start exercising, do I even need Wegovy?" It's a reasonable thing to wonder, and it deserves a straight answer. For most people who meet the clinical threshold for Wegovy (a BMI of 30 or above, or 27 with a weight-related condition) diet and exercise alone haven't produced sustained results, often through no fault of their own. Weight biology is shaped by hormones, genetics and set-point physiology in ways that willpower and walking don't easily override. That's not a defeatist position; it's what the evidence shows.
Wegovy addresses appetite signalling directly. Exercise addresses body composition and cardiovascular health. Used together, they address different things. The question isn't really "which one?", it's "do I want the best of both?" For people who find exercising while on semaglutide difficult early on because of nausea or fatigue, that's also worth discussing: those side effects are real, they're usually temporary, and pacing your activity around them is sensible. NHS guidance on weight-management injections confirms that wraparound lifestyle support is part of the intended treatment model, not an optional extra.
If you're considering Wegovy and wondering how to approach activity, the honest starting point is: do what you can sustain. A 15-minute walk you actually do is worth more than a gym programme you abandon. As appetite changes and energy improves on the medicine, many people find it easier to do more, not as a duty, but because they feel better.
Specific exercise planning on Wegovy is something our prescribers are well placed to discuss in the context of your health history, not as generic advice. Every consultation at nume is reviewed by a real prescriber, not an automated system, and that clinical relationship continues throughout your treatment. If you're already on semaglutide and finding activity harder than expected, or you want to understand how to structure movement alongside treatment, that's exactly the kind of question to raise at your next clinical review.
When you're ready to find out whether Wegovy is clinically appropriate for you, our free consultation is the place to start. Speak to our prescribers through our weight-loss treatments page, same-day clinical review, no waiting list.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.